The nation of Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive biological samples.
This move became public after a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson later stated that the US was demanding access to health data for research and commercial gain while refused to guarantee the resulting advantages from any future vaccines.
"We must now begin the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more negotiations to reach a deal acceptable to both sides so the country's critical HIV treatment initiative can continue.
Wider Implications
This development comes after a comparable situation in Kenya, where a high court suspended a related deal with the US after concerns were filed about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had managed aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost transparency and accountability.
According to reports, Sixteen African countries have so far signed these new health pacts, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our nation would provide the raw materials for scientific discovery with no certainty that the final treatments would be available to our population if a new pandemic emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures previously established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This mechanism is designed to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that negotiations need to persist since a large portion of the country's Aids initiatives depended on foreign aid.
"Where technical issues arise, such as those involving information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the complex tensions between accepting vital international aid and safeguarding local interests in an increasingly data-driven world.